Implantable Cardioverter Defibrillator Market Size, Share and Industry Analysis By Product Type (Transvenous ICD, Subcutaneous ICD), End User (Hospitals & Clinics, Ambulatory Surgery Centers and Others) & Regional Forecast, 2019 - 2032

Table of Content:

1. Introduction

1.1. Research Scope

1.2. Market Segmentation

1.3. Research Methodology

1.4. Definitions and Assumptions

2. Executive Summary

3. Market Dynamics

3.1. Market Drivers

3.2. Market Restraints

3.3. Market Opportunities

4. Key Insights

4.1 Prevalence of Sudden Cardiac Arrest- Key Countries

4.2 Technological Developments in Implantable Defibrillators

4.3 Key Mergers and Acquisitions

5. Global Implantable Cardioverter Defibrillator (ICD) Market Analysis, Insights and Forecast,2015-2026

5.1. Key Findings / Summary

5.2 Market Analysis, Insights and Forecast – By Product Type

5.2.1 Transveneous ICD

5.2.1.1 Single Chamber ICD

5.2.1.2 Dual Chamber ICD

5.2.1.3 CRT-D(Cardiac Resynchronization Therapy- Defibrillator)

5.2.2 Subcutaneous ICD

5.3. Market Analysis, Insights and Forecast – By End User

5.3.1 Clinics and Hospitals

5.3.2 Ambulatory Surgery Centers and Others

5.4. Market Analysis, Insights and Forecast – By Region

5.4.1 North America

5.4.2 Europe

5.4.3 Asia Pacific

5.4.4 Rest of the World

6. North America Implantable Cardioverter Defibrillator (ICD) Market Analysis, Insights and Forecast, 2015-2026

6.1. Key Findings / Summary

6.2. Market Analysis, Insights and Forecast – By Product Type

6.2.1 Transveneous ICD

6.2.1.1 Single Chamber ICD

6.2.1.2 Dual Chamber ICD

6.2.1.3 CRT-D(Cardiac Resynchronization Therapy- Defibrillator)

6.2.2 Subcutaneous ICD

6.3. Market Analysis, Insights and Forecast – By End User

6.3.1 Clinics and Hospitals

6.3.2 Ambulatory Surgery Centers and Others

6.4. Market Analysis, Insights and Forecast – By Country

6.4.1 U.S.

6.4.2 Canada

7. Europe Implantable Cardioverter Defibrillator (ICD) Market Analysis, Insights and Forecast,2015-2026

7.1. Key Findings / Summary

7.2. Market Analysis, Insights and Forecast – By Product Type

7.2.1 Transveneous ICD

7.2.1.1 Single Chamber ICD

7.2.1.2 Dual Chamber ICD

7.2.1.3 CRT-D(Cardiac Resynchronization Therapy- Defibrillator)

7.2.2 Subcutaneous ICD

7.3. Market Analysis, Insights and Forecast – By End User

7.3.1 Clinics and Hospitals

7.3.2 Ambulatory Surgery Centers and Others

7.4. Market Analysis, Insights and Forecast – By Country/ Sub-region

7.4.1 U.K.

7.4.2 Germany

7.4.3 France

7.4.4 Italy

7.4.5 Spain

7.4.6 Scandinavia

7.4.7 Rest of Europe

8. Asia Pacific Implantable Cardioverter Defibrillator (ICD) Market Analysis, Insights and Forecast, 2015-2026

8.1. Key Findings / Summary

8.2. Market Analysis, Insights and Forecast – By Product Type

8.2.1 Transveneous ICD

8.2.1.1 Single Chamber ICD

8.2.1.2 Dual Chamber ICD

8.2.1.3 CRT-D(Cardiac Resynchronization Therapy- Defibrillator)

8.2.2 Subcutaneous ICD

8.3. Market Analysis, Insights and Forecast – By End User

8.3.1 Clinics and Hospitals

8.3.2 Ambulatory Surgery Centers and Others

8.4. Market Analysis, Insights and Forecast – By Country/ Sub-region

8.4.1 China

8.4.2 India

8.4.3 Japan

8.4.4 Australia

8.4.5 South East Asia

8.4.6 Rest ofAsia Pacific

9. Rest of the World Implantable Cardioverter Defibrillator (ICD) Market Analysis, Insights and Forecast, 2015-2026

9.1. Key Findings / Summary

9.2. Market Analysis, Insights and Forecast – By Product Type

9.2.1 Transveneous ICD

9.2.1.1 Single Chamber ICD

9.2.1.2 Dual Chamber ICD

9.2.1.3 CRT-D(Cardiac Resynchronization Therapy- Defibrillator)

9.2.2 Subcutaneous ICD

9.3. Market Analysis, Insights and Forecast – By End User

9.3.1 Clinics and Hospitals

9.3.2 Ambulatory Surgery Centers and Others

10. Competitive Analysis

10.1. Key Industry Developments

10.2. Global Market Share Analysis (2018)

10.3. Comparative Analysis –Major Players

10.4. Company Profiles (Overview,Products & Services, SWOT Analysis, Recent Developments, Strategies,Financials (Based on Availability))

10.4.1 Boston Scientific Corporation

10.4.2 Biotronik

10.4.3 Medtronic

10.4.4 LivaNova PLC

10.4.5 Abbott

10.4.6 MicroPort

10.4.7 Other Prominent Players

11. Strategic Recommendations